| Ranibizumab for neovascular age-related macular degeneration PJ Rosenfeld, DM Brown, JS Heier, DS Boyer, PK Kaiser, CY Chung, ... New England Journal of Medicine 355 (14), 1419-1431, 2006 | 7273 | 2006 |
| Ranibizumab versus verteporfin for neovascular age-related macular degeneration DM Brown, PK Kaiser, M Michels, G Soubrane, JS Heier, RY Kim, JP Sy, ... New England Journal of Medicine 355 (14), 1432-1444, 2006 | 4480 | 2006 |
| Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration JS Heier, DM Brown, V Chong, JF Korobelnik, PK Kaiser, QD Nguyen, ... Ophthalmology 119 (12), 2537-2548, 2012 | 2792 | 2012 |
| Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study DM Brown, M Michels, PK Kaiser, JS Heier, JP Sy, T Ianchulev Ophthalmology 116 (1), 57-65. e5, 2009 | 1778 | 2009 |
| Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion JA Haller, F Bandello, R Belfort Jr, MS Blumenkranz, M Gillies, J Heier, ... Ophthalmology 117 (6), 1134-1146. e3, 2010 | 1338 | 2010 |
| Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study PA Campochiaro, JS Heier, L Feiner, S Gray, N Saroj, AC Rundle, ... Ophthalmology 117 (6), 1102-1112. e1, 2010 | 1236 | 2010 |
| Intravitreal aflibercept for diabetic macular edema JF Korobelnik, DV Do, U Schmidt-Erfurth, DS Boyer, FG Holz, JS Heier, ... Ophthalmology 121 (11), 2247-2254, 2014 | 1052 | 2014 |
| Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six–week results of the VIEW studies U Schmidt-Erfurth, PK Kaiser, JF Korobelnik, DM Brown, V Chong, ... Ophthalmology 121 (1), 193-201, 2014 | 1002 | 2014 |
| Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results JA Haller, F Bandello, R Belfort Jr, MS Blumenkranz, M Gillies, J Heier, ... Ophthalmology 118 (12), 2453-2460, 2011 | 916 | 2011 |
| Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies DM Brown, U Schmidt-Erfurth, DV Do, FG Holz, DS Boyer, E Midena, ... Ophthalmology 122 (10), 2044-2052, 2015 | 704 | 2015 |
| Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration BG Busbee, AC Ho, DM Brown, JS Heier, IJ Suñer, Z Li, RG Rubio, P Lai, ... Ophthalmology 120 (5), 1046-1056, 2013 | 622 | 2013 |
| Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration W Chen, D Stambolian, AO Edwards, KE Branham, M Othman, ... Proceedings of the National Academy of Sciences 107 (16), 7401-7406, 2010 | 620 | 2010 |
| Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial JS Heier, PA Campochiaro, L Yau, Z Li, N Saroj, RG Rubio, P Lai Ophthalmology 119 (4), 802-809, 2012 | 603 | 2012 |
| Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study JS Heier, AN Antoszyk, PR Pavan, SR Leff, PJ Rosenfeld, TA Ciulla, ... Ophthalmology 113 (4), 633-642. e4, 2006 | 534 | 2006 |
| One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema DV Do, QD Nguyen, D Boyer, U Schmidt-Erfurth, DM Brown, R Vitti, ... Ophthalmology 119 (8), 1658-1665, 2012 | 520 | 2012 |
| Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial DS Liao, FV Grossi, D El Mehdi, MR Gerber, DM Brown, JS Heier, ... Ophthalmology 127 (2), 186-195, 2020 | 499 | 2020 |
| A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema DW Chun, JS Heier, TM Topping, JS Duker, JM Bankert Ophthalmology 113 (10), 1706-1712, 2006 | 486 | 2006 |
| Intravitreal aflibercept for diabetic macular edema: 148-week results from the VISTA and VIVID studies JS Heier, JF Korobelnik, DM Brown, U Schmidt-Erfurth, DV Do, E Midena, ... Ophthalmology 123 (11), 2376-2385, 2016 | 485 | 2016 |
| Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study DM Brown, JS Heier, WL Clark, DS Boyer, R Vitti, AJ Berliner, O Zeitz, ... American journal of ophthalmology 155 (3), 429-437. e7, 2013 | 465 | 2013 |
| Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double … JS Heier, AM Khanani, CQ Ruiz, K Basu, PJ Ferrone, C Brittain, ... The Lancet 399 (10326), 729-740, 2022 | 448 | 2022 |
